Corneal astigmatism independent of patient age at surgeryOptimal planning for correction of pre-existing corneal astigmatism at the time of cataract surgery should take into account an age-related, against-the-rule (ATR) shift.
In this issue
What to do when the rhexis won’t tearMetabolic insult from silicone oil exposure can cause lens epithelial cells to undergo fibrous metaplasia, making the lens capsule resistant to tearing. Instead of persisting in trying to initiate a tear, surgeons should use an instrument to cut through the fibrotic material. This non-standard approach for opening the capsule recognizes potential for capsular fibrosis in eyes filled with silicone oil. Integrating computer-assisted toric IOL implantation February 01, 2017By Bryan S. Lee MD JDSince making the switch to a markerless toric alignment system, Bryan S. Lee, MD, JD, explains how the technology has eliminated ink marking from his surgical regimen. Upgrades to intraop aberrometer enhance surgical feedback February 01, 2017By Nancy GrovesA sophisticated integrated formula for IOL power prediction is the featured capability in upgrades to Clarity Medical Systems’ intraoperative wavefront aberrometer. Intracameral phenylephrine/ketorolac superior to intracameral epinephrine February 01, 2017By Lynda ChartersPhenylephrine 1%/ketorolac injection 0.3% added to ophthalmic irrigation solution and administered intracamerally during cataract surgery was associated with a statistically significant reduction in surgical time, intraoperative complications, and use of pupil dilating devices and with a statistically significant improvement in best-corrected visual acuity. Why Acanthamoeba diagnosis is often challenging
February 01, 2017Having an awareness of current best practices—such as epidemiology, risk factors, signs and symptoms, and tests—can be key to identifying and treating corneal infections.
Transzonular intravitreal injection eases treatment burden after cataract surgery February 01, 2017By Lynda ChartersAn intraoperative injection of a compounded formulation of triamcinolone acetonide, moxifloxacin, and vancomycin eliminated the need for supplemental postoperative medications in the vast majority of patients who underwent phacoemulsification and IOL implantation. Making phaco platform transition increases surgical safety, efficiencyWhen his surgery center was in the market for a new phacoemulsification platform, medical director Jonathan Solomon, MD, decided to switch from a unit equipped with a flow-based peristaltic pump to technology that features a vacuum-based Venturi system (Stellaris PC, Bausch + Lomb).